Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study
Clinical trial NCT01973920 · COMPLETED
Trial details
- NCT number
- NCT01973920
- Sponsor
- Oshadi Drug Administration
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2017-02-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.